Sanctuary Advisors LLC Grows Holdings in iShares Biotechnology ETF $IBB

Sanctuary Advisors LLC raised its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 15.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 45,881 shares of the financial services provider’s stock after purchasing an additional 6,112 shares during the quarter. Sanctuary Advisors LLC owned 0.10% of iShares Biotechnology ETF worth $7,747,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in the stock. Basepoint Wealth LLC bought a new position in shares of iShares Biotechnology ETF in the fourth quarter worth about $26,000. Cary Street Partners Financial LLC bought a new stake in iShares Biotechnology ETF during the 4th quarter valued at about $29,000. Darwin Wealth Management LLC bought a new stake in iShares Biotechnology ETF during the 2nd quarter valued at about $25,000. Caitlin John LLC purchased a new stake in iShares Biotechnology ETF in the 4th quarter valued at about $34,000. Finally, Cornerstone Planning Group LLC bought a new position in iShares Biotechnology ETF in the 4th quarter worth about $35,000. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Up 0.1%

Shares of NASDAQ:IBB opened at $189.76 on Friday. The firm’s 50 day simple moving average is $177.79 and its 200-day simple moving average is $173.40. iShares Biotechnology ETF has a one year low of $128.84 and a one year high of $199.05.

iShares Biotechnology ETF Cuts Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, June 18th. Investors of record on Monday, June 15th were paid a $0.0238 dividend. The ex-dividend date of this dividend was Monday, June 15th. This represents a $0.10 annualized dividend and a yield of 0.1%.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.